Equillium to Participate in Upcoming Investor Conferences
News originally published by
GlobeNewswireLA JOLLA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat serious autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:
Stifel 2026 Healthcare Conference
Format: Fireside Chat & 1x1 Meetings
Date: Thursday, November 12, 2026
Time: 9:20 AM EST
2026 Jefferies Global Healthcare Conference in London
Format: 1x1 Meetings
Date: Tuesday, November 17 – Thursday, November 19, 2026
Members of the Equillium management team will be available to meet with investors who are registered to attend each conference.
About Equillium
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat serious autoimmune and inflammatory disorders.
For more information, visit www.equilliumbio.com.
Investor Contact
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
